| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule: David F. Lehmann, M.D., Pharm.D.,
Bruce M. Psaty, M.D., Ph.D.
and Where Do We Stand?
Hylton V. Joffe, M.D., M.M.Sc.
Food and Drug Administration, CDER
David F. Lehmann, M.D., Pharm.D., FCP
Development
Braj B. Lohray, Ph.D.
Bhurid Research Laboratory
Bopal, India
David F. Lehmann, M.D., Pharm.D., FCP, SUNY Upstate Medical University, Syracuse, NY Bruce M. Psaty, M.D., Ph.D., MPH, Professor of Medicine; Co-Director of Cardiovascular Health, University of Washington, Seattle, WA Hylton V. Joffe, M.D., M.M.Sc., Lead Medical Officer - Diabetes Drug Group, Food and Drug Administration, CDER, Silver Spring, MD Braj B. Lohray, Ph.D., Chief Executive Officer, Bhuvid Research Laboratory, Bopal, India
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||